vs
Side-by-side financial comparison of Prime Medicine, Inc. (PRME) and Reborn Coffee, Inc. (REBN). Click either name above to swap in a different company.
Reborn Coffee, Inc. is the larger business by last-quarter revenue ($1.4M vs $838.0K, roughly 1.6× Prime Medicine, Inc.). Reborn Coffee, Inc. runs the higher net margin — -254.3% vs -5498.7%, a 5244.4% gap on every dollar of revenue. On growth, Reborn Coffee, Inc. posted the faster year-over-year revenue change (7.8% vs -61.6%).
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Reborn Coffee, Inc. is a specialty coffee roaster and retailer that offers premium single-origin and blended roasted coffee beans, handcrafted espresso drinks, baked snacks and related merchandise. It operates brick-and-mortar cafe locations primarily across the United States, alongside direct-to-consumer online sales and wholesale distribution to foodservice partners, with a core focus on ethically sourced, high-quality coffee products.
PRME vs REBN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $838.0K | $1.4M |
| Net Profit | $-46.1M | $-3.4M |
| Gross Margin | — | — |
| Operating Margin | -5800.5% | -224.7% |
| Net Margin | -5498.7% | -254.3% |
| Revenue YoY | -61.6% | 7.8% |
| Net Profit YoY | -9.0% | -379.3% |
| EPS (diluted) | $-0.22 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $838.0K | — | ||
| Q3 25 | $1.2M | $1.4M | ||
| Q2 25 | $1.1M | $1.8M | ||
| Q1 25 | $1.5M | $1.7M | ||
| Q4 24 | $2.2M | $1.8M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | $0 | $1.4M | ||
| Q1 24 | $591.0K | $1.5M |
| Q4 25 | $-46.1M | — | ||
| Q3 25 | $-50.6M | $-3.4M | ||
| Q2 25 | $-52.6M | $-5.3M | ||
| Q1 25 | $-51.9M | $-2.2M | ||
| Q4 24 | $-42.3M | $-1.8M | ||
| Q3 24 | — | $-719.7K | ||
| Q2 24 | $-55.3M | $-1.3M | ||
| Q1 24 | $-45.8M | $-990.5K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 98.7% |
| Q4 25 | -5800.5% | — | ||
| Q3 25 | -4406.0% | -224.7% | ||
| Q2 25 | -4787.2% | -240.2% | ||
| Q1 25 | -3603.3% | -100.2% | ||
| Q4 24 | -2025.7% | -95.2% | ||
| Q3 24 | — | -57.6% | ||
| Q2 24 | — | -97.4% | ||
| Q1 24 | -8179.5% | -56.9% |
| Q4 25 | -5498.7% | — | ||
| Q3 25 | -4129.1% | -254.3% | ||
| Q2 25 | -4716.7% | -291.0% | ||
| Q1 25 | -3568.8% | -129.4% | ||
| Q4 24 | -1936.6% | -100.0% | ||
| Q3 24 | — | -57.2% | ||
| Q2 24 | — | -95.9% | ||
| Q1 24 | -7743.0% | -65.3% |
| Q4 25 | $-0.22 | — | ||
| Q3 25 | $-0.32 | $-0.68 | ||
| Q2 25 | $-0.41 | $-1.15 | ||
| Q1 25 | $-0.40 | $-0.47 | ||
| Q4 24 | $-0.31 | $-0.28 | ||
| Q3 24 | — | $-0.30 | ||
| Q2 24 | $-0.46 | $-0.48 | ||
| Q1 24 | $-0.44 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.0M | $44.0K |
| Total DebtLower is stronger | — | $500.0K |
| Stockholders' EquityBook value | $120.9M | $-3.4M |
| Total Assets | $342.7M | $6.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.0M | — | ||
| Q3 25 | $71.4M | $44.0K | ||
| Q2 25 | $53.8M | $77.9K | ||
| Q1 25 | $91.9M | $777.1K | ||
| Q4 24 | $182.5M | $158.2K | ||
| Q3 24 | — | $105.9K | ||
| Q2 24 | $55.6M | $617.1K | ||
| Q1 24 | $94.2M | $70.3K |
| Q4 25 | — | — | ||
| Q3 25 | — | $500.0K | ||
| Q2 25 | — | $500.0K | ||
| Q1 25 | — | $500.0K | ||
| Q4 24 | — | $500.0K | ||
| Q3 24 | — | $500.0K | ||
| Q2 24 | — | $500.0K | ||
| Q1 24 | — | $500.0K |
| Q4 25 | $120.9M | — | ||
| Q3 25 | $161.8M | $-3.4M | ||
| Q2 25 | $60.9M | $-1.9M | ||
| Q1 25 | $106.9M | $415.6K | ||
| Q4 24 | $153.1M | $2.6M | ||
| Q3 24 | — | $2.7M | ||
| Q2 24 | $196.6M | $2.5M | ||
| Q1 24 | $243.8M | $2.6M |
| Q4 25 | $342.7M | — | ||
| Q3 25 | $385.0M | $6.2M | ||
| Q2 25 | $279.0M | $6.4M | ||
| Q1 25 | $328.2M | $8.1M | ||
| Q4 24 | $297.5M | $7.8M | ||
| Q3 24 | — | $9.6M | ||
| Q2 24 | $259.7M | $10.5M | ||
| Q1 24 | $311.4M | $10.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-37.3M | $-1.6M |
| Free Cash FlowOCF − Capex | $-37.5M | — |
| FCF MarginFCF / Revenue | -4480.4% | — |
| Capex IntensityCapex / Revenue | 34.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-167.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-37.3M | — | ||
| Q3 25 | $-35.0M | $-1.6M | ||
| Q2 25 | $-41.4M | $-3.6M | ||
| Q1 25 | $-48.9M | $464.6K | ||
| Q4 24 | $16.2M | $-132.6K | ||
| Q3 24 | — | $-424.0K | ||
| Q2 24 | $-45.5M | $-961.8K | ||
| Q1 24 | $-67.7M | $-1.9M |
| Q4 25 | $-37.5M | — | ||
| Q3 25 | $-35.3M | — | ||
| Q2 25 | $-43.0M | — | ||
| Q1 25 | $-51.3M | — | ||
| Q4 24 | $14.5M | $-600.9K | ||
| Q3 24 | — | $-424.0K | ||
| Q2 24 | $-47.4M | $-1.3M | ||
| Q1 24 | $-70.0M | $-2.9M |
| Q4 25 | -4480.4% | — | ||
| Q3 25 | -2880.5% | — | ||
| Q2 25 | -3855.1% | — | ||
| Q1 25 | -3526.8% | — | ||
| Q4 24 | 662.1% | -33.8% | ||
| Q3 24 | — | -33.7% | ||
| Q2 24 | — | -95.3% | ||
| Q1 24 | -11849.6% | -192.4% |
| Q4 25 | 34.6% | — | ||
| Q3 25 | 20.2% | 0.0% | ||
| Q2 25 | 141.0% | — | ||
| Q1 25 | 166.6% | — | ||
| Q4 24 | 82.0% | 26.3% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 25.2% | ||
| Q1 24 | 393.2% | 65.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRME
Segment breakdown not available.
REBN
| Stores | $1.1M | 83% |
| Other | $229.9K | 17% |
